ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19.

Valur Emilsson Elias Freyr Gudmundsson Thor Aspelund Brynjólfur Gauti Guðrúnar Jónsson Alexander Gudjonsson Lenore J Launer John R Lamb Valborg Gudmundsdottir Lori L Jennings Vilmundur G Gudnason

Published in: medRxiv : the preprint server for health sciences (2020)

ACE2 levels are upregulated in some patient groups with comorbidities linked to COVID-19 and as such may have an emerging role as a circulating biomarker for severity of outcome in COVID-19.

Keyphrases

coronavirus disease
sars cov
angiotensin ii
angiotensin converting enzyme
respiratory syndrome coronavirus
case report
drug induced